Abstract:The non-receptor protein tyrosine kinase c-Src regulates diverse biological processes by associating with multiple signaling and structural molecules. Overexpression of c-Src occurs in pancreatic cancer and can be predictive of poor prognosis. The aim of this study was to investigate the inhibitory effects of plasmid-based siRNAs targeting the human c-Src gene on proliferation and angiogenesis in the human pancreatic adenocarcinoma cell line Panc-1. Three siRNAs targeting the c-Src gene were transfected into the Panc-1 pancreatic adenocarcinoma cell line mediated by Lipofectamine. Transfection efficiency was assessed by flow cytometry. Real-time quantitative PCR (RQ-PCR) was employed to detect the expression of c-Src mRNA, and the most effective siRNA was chosen to be cloned into a plasmid. Two single-strand DNA templates were designed according to the most effective siRNA sequences. The short hairpin RNA (shRNA) plasm id targeting c-Src with pGPU6/green fluorescent protein (GFP)/Neo vector psiRNA-c-Src was constructed. Sequencing was performed to check whether the plasmid was constructed correctly. Panc-1 cells were transfected with psiRNA-c-Src and the negative control plasmid (psiRNA-N), respectively. Following selection with G418, the transfected monoclonal cells were chosen. GFP was evaluated by flow cytometry and fluorescence microscopy to estimate transfection efficiency. RQ-PCR and western blotting were used to detect c-Src silencing efficiency. To verify the effects of gemcitabine chemoresistance of c-Src expression, MTT assay was performed. ELISA was used to determine VEGF levels in culture supernatants. In a nude mouse model, tumor growth was studied, c-Src, VEGF expression and microvessel density in tumor tissue were measured by immunohistochemistry. The transfection efficiency of siRNA in the Panc-1 cell line was above 90%, the most effective siRNA could suppress expression of the c-Src gene with an inhibition efficiency of 86.1%. Sequencing confirmed that the c-Src siRNA plasmid was successfully constructed. MTT assay indicated that the effect of gemcitabine-induced cytotoxicity was markedly increased in the psiRNA-c-Src group (P<0.05). Meanwhile, the expression of VEGF in vitro was reduced significantly (P<0.05) in the psiRNA-c-Src group. In nude mice bearing tumors, c-Src, VEGF expression and MVD were decreased in tumors produced from psiRNA-c-Src transfected cells (P<0.05). In summary, the siRNA expression constructs targeting c-Src could specifically suppress c-Src expression, inhibit VEGF expression, inhibit cell proliferation and enhance gemcitabine chemosensitivity in vitro. C-Src gene silencingwas able to inhibit angiogenesis of tumors in vivo. These findings demonstrate that the c-Src targeting gene silencing approach has the potential to serve as a novel tool for pancreatic carcinoma treatment.

Effect of Sirna Silencing EphB2 Expression on Proliferation and Apoptosis of Pancreatic Cancer CFPAC-1 Cells

Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.

Influence of Stable Inhibition of XIAP and Survivin Expression on Biological Characteristics of Pancreatic Cancer Cells

[Sirna Targeted Against Survivin Induces Apoptosis of Pancreatic Cancer Cells].

[Effects of Epidermal Growth Factor Receptor Gene Silencing Mediated by Short Hairpin RNA on Proliferation and Apoptosis of Human Tongue Carcinoma Cells].

A Study of the Suppressive Effect on Human Pancreatic Adenocarcinoma Cell Proliferation and Angiogenesis by Stable Plasmid-Based Sirna Silencing of C-Src Gene Expression.

Effect of enhancing the radiosensitivity of pancreatic cancer cell line PC-2 by siRNA against Survivin.

Inhibition Effect of Pancreatic Cancer PANC-1 Cells by Shrna Targeting on EGFR

Inhibitory effect of RNAi on the expression of EphB4 gene in human prostate cancer PC3 cells

[Effect of RNA Interference Targeting Neuropilin-2 Gene on Proliferation and Apoptosis of Colon Cancer Cell Line HCT-8]

Effects and Mechanisms of Combined Suppression of Epidermal Growth Factor Receptor and Hedgehog Signaling on Proliferation in Pancreatic Cancer Cells

siRNA AGAINST SURVIVIN SUPPRESSES THE PROLIFERATION OF PANCREATIC CANCER CELL PC-2 AND INDUCES ITS APOPTOSIS

Experimental study on lentiviral vector-mediad RNA interference inhibiting XIAP expression and influencing proliferation and apoptosis of human pancreatic cancer cells

Targeted gene silencing of homo sapiens eukaryotic translation elongation factor 1 alpha 2 inhibits migration and invasion of human pancreatic cancer cell line BxPC-3 in vitro

Effect of Sirna Targeting HER2/neu on the Proliferation and Viability of Prostate Cancer PC-3M Cells.

Study of Inhibiting The Expression of Survivin in Pancreatic Cancer Cells with RNA Interference

Effects of Silencing E2F3 Expression Using RNAi with pAAV Virus Exprsessing Vector in Prostate Cancer CeU Line LNCAP

Effects of lentiviral-delivered CDC25B2 siRNA on biological behaviors of human pancreatic cancer cell line CFPAC-1

Effects of Silencing SIRT1 Gene Expression on Proliferation and Apoptosis of Pancreatic Cancer Cell Line PANC1

Down-regulation of Hent_1 by RNAi Increasing the Cytotoxicity of 5-Fluorouracil to Pancreatic Cancer Cells

Combined effects of EGFR and Hedgehog signaling pathway inhibition on the proliferation and apoptosis of pancreatic cancer cells.